Amylyx: AdComm Decision Unlikely To Increase ALS Drug Approval
An FDA Advisory Committee will look at fresh data presented by ALS drug developer Amylyx (AMLX) as it attempts to secure accelerated approval. Read more here.
Source: seekingalpha.com
Stay updated with breaking news from Limb Isometric Strength. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
An FDA Advisory Committee will look at fresh data presented by ALS drug developer Amylyx (AMLX) as it attempts to secure accelerated approval. Read more here.
A US Food and Drug Administration advisory committee is unconvinced by that a new drug for amyotrophic lateral sclerosis is effective.